#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	11858	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2143	545.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1404	1404	C	707	C	692	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22542	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3511	635.9	0	.	n	.	0	T695C	SNP	695	695	T	1007	1007	C	691	C,T	679,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22542	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3511	635.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1649	1649	A	728	A,G	722,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22542	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3511	635.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2283	2283	C	694	C	683	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22542	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3511	635.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2357	2357	A	684	A	674	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22542	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3511	635.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2909	2909	C	644	C,T	630,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22542	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3511	635.9	0	HET	.	.	.	A790G	.	790	790	A	1102	1102	A	716	A,G	564,142	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	14	blaTEM	861	111	98.2	blaTEM.l15.c30.ctg.1	313	1.6	0	.	p	.	0	I3T	NONSYN	7	9	ATT	209	211	ACT	1;1;1	A;C,T;T	1;0,1;1	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	14	blaTEM	861	111	98.2	blaTEM.l15.c30.ctg.1	313	1.6	0	.	p	.	0	P12S	NONSYN	34	36	CCC	236	238	TCC	2;2;2	T;C;C	2;1;2	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	1584	folP	855	855	100.0	folP.l15.c17.ctg.1	1776	88.8	1	SNP	p	R229S	0	.	.	685	687	CGC	1117	1119	CGC	155;157;156	C;G;C	151;153;152	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4264	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3392	124.6	1	SNP	p	S91F	0	.	.	271	273	TCC	562	564	TCC	150;151;153	T;C,T;C,A	147;147,1;150,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4264	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3392	124.6	1	SNP	p	D95N	0	.	.	283	285	GAC	574	576	GAC	147;147;147	G;A,G;C	143;143,2;145	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4264	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3392	124.6	1	SNP	p	D95G	0	.	.	283	285	GAC	574	576	GAC	147;147;147	G;A,G;C	143;143,2;145	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1300	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1387	92.7	1	SNP	p	G45D	1	.	.	133	135	GAC	518	520	GAC	140;141;143	G;A;C	138;139;141	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	726	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1065	67.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	3888	parC	2304	2304	99.83	parC.l6.c30.ctg.1	3347	115.6	1	SNP	p	D86N	0	.	.	256	258	GAC	845	847	GAC	172;174;176	G,C;A;C	171,1;170;174	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	3888	parC	2304	2304	99.83	parC.l6.c30.ctg.1	3347	115.6	1	SNP	p	S88P	0	.	.	262	264	TCC	851	853	TCC	177;178;178	T;C;C	173;176;177	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3154	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2711	115.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1554	1556	GGC	176;177;173	G;G;C	172;168;167	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	0	.	p	.	0	P552L	NONSYN	1654	1656	CCG	1966	1968	CTG	95;95;91	C,G;T;G	79,3;74;75	.	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1243	1245	GCA	146;148;148	G;C;A	142;142;143	penA.43.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1246	1248	ATC	151;151;153	A;T;C	146;148;147	penA.43.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1258	1260	GTG	155;154;156	G;T;G	153;149;154	penA.43.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1258	1260	GTG	155;154;156	G;T;G	153;149;154	penA.43.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1762	1764	ACC	126;125;128	A;C;C	121;123;125	penA.43.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1816	1818	GTG	137;130;131	G;T,G;G	128;108,4;123	penA.43.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1816	1818	GTG	137;130;131	G;T,G;G	128;108,4;123	penA.43.002:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1939	1941	GGC	122;121;121	G;G;C	120;116;113	penA.43.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3018	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2427	123.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1948	1950	GGC	117;114;114	G,C;G;C,T	110,1;109;109,1	penA.43.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	4620	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3101	147.2	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1640	1642	CCG	173;176;173	C;C;G	160;170;164	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1880	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1847	100.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	395	397	GGC	125;126;125	G,T;G;C	122,1;122;121	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1880	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1847	100.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	577	577	C	130	C,G	116,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2398	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1458	162.1	0	.	p	.	0	G120N	NONSYN	358	360	GGC	608	610	AAC	186;185;189	A;A;C	182;180;182	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2398	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1458	162.1	0	.	p	.	0	E212G	NONSYN	634	636	GAA	884	886	GGA	201;202;199	G;G;A	199;202;196	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2398	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1458	162.1	0	.	p	.	0	Y216_S217del	DEL	646	646	T	896	896	T	198	T	197	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2398	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1458	162.1	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1124	1126	AAT	221;219;219	A;A;T	217;215;213	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2398	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1458	162.1	1	SNP	p	A121D	1	.	.	361	363	GAC	611	613	GAC	184;181;182	G;A;C	175;175;175	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2398	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1458	162.1	1	SNP	p	D121N	0	.	.	361	363	GAC	611	613	GAC	184;181;182	G;A;C	175;175;175	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8230	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4962	164.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	984	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1135	85.8	1	SNP	p	V57M	1	.	.	169	171	ATG	511	513	ATG	172;172;173	A;T;G	169;167;171	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
